Journal profile · Pharmacology & Pharmacy
Drug Metabolism Reviews
ISSN 0360-2532 · eISSN 1097-9883 · Informa Healthcare · UNITED STATES · Quarterly · Founded 1972
Drug Metabolism Reviews: CAS Zone 3 · Medicine (2025 upgraded edition); impact factor 4.59; hybrid open access; median 87 days to acceptance (50 articles, last 24 months); community-reported acceptance: moderate; 25 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Drug Metabolism Reviews is published by Informa Healthcare and is in Zone 3 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Pharmacogenetics and Drug Metabolism, Drug Transport and Resistance Mechanisms and Drug-Induced Hepatotoxicity and Protection, together about 45.1% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Drug Metabolism Reviews consistently provides critically needed reviews of an impressive array of drug metabolism research-covering established, new, and potential drugs; environmentally toxic chemicals; absorption; metabolism and excretion; and enzymology of all living species. Additionally, the journal offers new hypotheses of interest to diverse groups of medical professionals including pharmacologists, toxicologists, chemists, microbiologists, pharmacokineticists, immunologists, mass spectroscopists, as well as enzymologists working in xenobiotic biotransformation.
Source: LetPub
Research area (LetPub): Pharmacology & Pharmacy
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pharmacogenetics and Drug MetabolismPharmacology, Toxicology and Pharmaceutics28.6%
- Drug Transport and Resistance MechanismsMedicine11.1%
- Drug-Induced Hepatotoxicity and ProtectionPharmacology, Toxicology and Pharmaceutics5.5%
- Computational Drug Discovery MethodsComputer Science4.4%
- Carcinogens and Genotoxicity AssessmentBiochemistry, Genetics and Molecular Biology4.3%
- Eicosanoids and Hypertension PharmacologyBiochemistry, Genetics and Molecular Biology4%
- Analytical Chemistry and ChromatographyChemistry3.7%
- Metabolism and Genetic DisordersBiochemistry, Genetics and Molecular Biology3.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 2 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Pharmacology & Pharmacy | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Pharmacology & Pharmacy | Zone 2 |
Top journal: noReview journal: yes
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.59LetPub ·
- CiteScore 2026-06
- 7.1LetPub ·
- SJR 2026-06
- 0.93LetPub ·
- SNIP 2026-06
- 1LetPub ·
- h-index
- 89LetPub ·
- h-index
- 145OpenAlex ·
- i10-index
- 1,070OpenAlex ·
- 2-year mean citedness
- 4.92OpenAlex ·
- Self-citation rate
- 4.3%LetPub ·
- Share of gold OA articles
- 10.94%LetPub ·
Volume
- Articles per year
- 20LetPub ·
Articles by year OpenAlex count · 1,815 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 25 | 6 | 18 |
| 2025 | 25 | 6 | 96 |
| 2024 | 24 | 5 | 250 |
| 2023 | 21 | 3 | 292 |
| 2022 | 23 | 5 | 407 |
| 2021 | 26 | 8 | 601 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
87 daysMedian, submission to acceptance · P25–P75 57 days – 175 days
- Acceptance to online
- median 17 days (50 articles)
- Submission to online
- median 106 days
- Sample
- 50 articles with submission and acceptance dates (56 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average acceptance (community reports)
- ModerateLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Informa Healthcare
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Quarterly
- Founded
- 1972
- ISSN
- 0360-2532
- Electronic ISSN
- 1097-9883
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
FAQ
Frequently asked questions about Drug Metabolism Reviews
What CAS zone is Drug Metabolism Reviews in?
In the 2025 upgraded edition of the CAS Journal Ranking, Drug Metabolism Reviews is in Zone 3 of Medicine, and in Zone 2 of the minor category Pharmacology & Pharmacy. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Drug Metabolism Reviews?
The latest impact factor listed by LetPub is 4.59; CiteScore 7.1, h-index 145.
How long does peer review take at Drug Metabolism Reviews?
Based on the dates recorded on 50 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 87 days (interquartile range 57–175 days); the community-reported acceptance is “Moderate”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Drug Metabolism Reviews?
According to LetPub and DOAJ records, Drug Metabolism Reviews is indexed in SCIE and Scopus.
Is Drug Metabolism Reviews open access, and what is the APC?
Drug Metabolism Reviews is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .